JP2008505985A5 - - Google Patents

Download PDF

Info

Publication number
JP2008505985A5
JP2008505985A5 JP2007527553A JP2007527553A JP2008505985A5 JP 2008505985 A5 JP2008505985 A5 JP 2008505985A5 JP 2007527553 A JP2007527553 A JP 2007527553A JP 2007527553 A JP2007527553 A JP 2007527553A JP 2008505985 A5 JP2008505985 A5 JP 2008505985A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
virus
conjugate
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007527553A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008505985A (ja
Filing date
Publication date
Priority claimed from US10/848,827 external-priority patent/US7314613B2/en
Application filed filed Critical
Publication of JP2008505985A publication Critical patent/JP2008505985A/ja
Publication of JP2008505985A5 publication Critical patent/JP2008505985A5/ja
Pending legal-status Critical Current

Links

JP2007527553A 2004-05-19 2005-05-18 インターフェロン−αポリペプチドおよび結合体 Pending JP2008505985A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/848,827 US7314613B2 (en) 2002-11-18 2004-05-19 Interferon-alpha polypeptides and conjugates
PCT/US2005/018103 WO2006083276A2 (en) 2004-05-19 2005-05-18 Interferon-alpha polypeptides and conjugates

Publications (2)

Publication Number Publication Date
JP2008505985A JP2008505985A (ja) 2008-02-28
JP2008505985A5 true JP2008505985A5 (enExample) 2008-07-03

Family

ID=36777639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527553A Pending JP2008505985A (ja) 2004-05-19 2005-05-18 インターフェロン−αポリペプチドおよび結合体

Country Status (4)

Country Link
US (8) US7314613B2 (enExample)
EP (1) EP1771198A2 (enExample)
JP (1) JP2008505985A (enExample)
WO (1) WO2006083276A2 (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
JP2002537762A (ja) * 1999-01-05 2002-11-12 トラスティーズ オブ ボストン ユニバーシティ 改良型核酸クローニング
US20040005673A1 (en) * 2001-06-29 2004-01-08 Kevin Jarrell System for manipulating nucleic acids
US20030017552A1 (en) * 2000-07-21 2003-01-23 Jarrell Kevin A. Modular vector systems
US7435562B2 (en) * 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
PT2298278E (pt) 2002-06-07 2016-02-25 Dyax Corp Prevenção e redução da perda de sangue e resposta inflamatória
US7314613B2 (en) * 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates
CA3050564A1 (en) * 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
CA2537113A1 (en) * 2003-08-29 2005-03-10 Dyax Corp. Modified protease inhibitors
BRPI0507169A (pt) * 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
ATE540110T1 (de) * 2004-11-11 2012-01-15 Modular Genetics Inc Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt
KR20080026135A (ko) * 2005-06-03 2008-03-24 암브룩스, 인코포레이티드 개선된 인간 인터페론 분자 및 이의 용도
US20080014616A1 (en) * 2006-07-11 2008-01-17 Kevin Jarrell Methods of introducing targeted diversity into nucleic acid molecules
AU2007338771A1 (en) * 2006-12-19 2008-07-03 Merrimack Pharmaceuticals, Inc. Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
CN1970572A (zh) * 2006-12-21 2007-05-30 北京三元基因工程有限公司 干扰素α突变体及其聚乙二醇衍生物
CN101675071B (zh) * 2007-05-02 2014-06-18 Ambrx公司 经修饰干扰素β多肽和其用途
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CN101525381B (zh) * 2008-03-04 2012-04-18 北京百川飞虹生物科技有限公司 一种重组复合干扰素及其表达载体的构建和表达
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
WO2009129616A1 (en) 2008-04-21 2009-10-29 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
JP2013516389A (ja) 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
US20100284962A1 (en) * 2009-05-06 2010-11-11 Oncopharmacologics, Inc. Modified tumor necrosis factor-beta
EP2440251A4 (en) 2009-06-09 2013-01-16 Defyrus Inc INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
ES2905545T3 (es) 2010-01-06 2022-04-11 Takeda Pharmaceuticals Co Proteínas de unión a calicreína plasmática
WO2011087627A1 (en) * 2010-01-15 2011-07-21 Biolex Therapeutics, Inc Stabilized interferon formulations
KR101303388B1 (ko) 2010-10-26 2013-09-03 한미사이언스 주식회사 지속형 인터페론 알파 결합체의 액상 제제
KR102011156B1 (ko) 2011-01-06 2019-08-16 다이액스 코포레이션 혈장 칼리크레인 결합 단백질
WO2012145386A1 (en) * 2011-04-21 2012-10-26 Baxter International Inc. Methods for isolating and quantifying antigen from vaccines
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
ES2899209T3 (es) 2012-09-19 2022-03-10 Microvascular Tissues Inc Composiciones y métodos para tratar y prevenir lesión y enfermedad tisular
JP6611720B2 (ja) 2013-09-03 2019-11-27 ジョージア テック リサーチ コーポレイション 熱安定性ワクチン製剤及びマイクロニードル
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for drops in macular edema as a result of diabetes
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
CN107046366B (zh) * 2016-02-05 2019-06-04 台达电子企业管理（上海）有限公司 电源变换器及其制备方法
SG10201609616TA (en) * 2016-09-06 2018-04-27 Apple Inc Electronic device with cooling fan
AU2021209045A1 (en) 2020-01-13 2022-07-28 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610830B1 (en) 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
US4414150A (en) 1980-11-10 1983-11-08 Genentech, Inc. Hybrid human leukocyte interferons
ES8302778A1 (es) 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
WO1983002461A1 (en) 1982-01-19 1983-07-21 Cetus Corp Multiclass hybrid interferons
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
ATE78262T1 (de) 1985-06-11 1992-08-15 Ciba Geigy Ag Hybrid-interferone.
US5372808A (en) 1990-10-17 1994-12-13 Amgen Inc. Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
ES2128348T3 (es) 1990-10-17 1999-05-16 Amgen Inc Obtencion de composiciones para el tratamiento de alteraciones de la proliferacion celular.
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5780021A (en) * 1993-03-05 1998-07-14 Georgetown University Method for treating type 1 diabetes using α-interferon and/or β-i
US5574138A (en) 1993-03-08 1996-11-12 Immunex Corporation Epithelium-derived T-cell factor
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
PT741577E (pt) 1994-03-07 2003-03-31 Imperial College Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
ATE375363T1 (de) 1997-07-14 2007-10-15 Bolder Biotechnology Inc Derivate des wachstumshormons und verwandte proteine
AU775937B2 (en) 1999-01-14 2004-08-19 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
WO2000052153A2 (en) 1999-03-02 2000-09-08 Maxygen, Inc. Method to identify ligands for orphan receptors
KR20020018197A (ko) 1999-05-19 2002-03-07 추후보정 Ｆｃ 융합 단백질로서의 인터페론-알파 단백질의 발현 및분비
US20040002474A1 (en) 1999-10-07 2004-01-01 Maxygen Inc. IFN-alpha homologues
AU8001300A (en) 1999-10-07 2001-05-10 Maxygen, Inc. Ifn-alpha homologues
NZ522847A (en) 2000-05-16 2004-11-26 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
US20020025304A1 (en) * 2000-06-16 2002-02-28 Croze Edward M. Novel interferon for the treatment of multiple sclerosis
WO2002044197A2 (en) 2000-12-01 2002-06-06 Fish Eleanor N Cytokine receptor binding peptides
KR100459105B1 (ko) 2001-02-15 2004-12-03 선바이오(주) 변형된 인터페론-알파 2ａ 및 2ｂ, 그리고 이들과 ＰＥＧ유도체와의 배합체
MXPA05005178A (es) 2002-11-15 2005-07-22 Hoffmann La Roche Isomeros posicionales del interferon alfa 2a (ifn) pegilado con una porcion de polietilenglicol grande (peg).
US7314613B2 (en) * 2002-11-18 2008-01-01 Maxygen, Inc. Interferon-alpha polypeptides and conjugates

Similar Documents

Publication Publication Date Title
JP2008507298A5 (enExample)
JP6290193B2 (ja) ペグ化ｏｘｍ変異体
RU2006145020A (ru) Полипептиды и конъюгаты интерферона-альфа
JP2013501038A5 (enExample)
RU2012107671A (ru) Композиция для лечения инфекции вирусом гепатита в
JP2008529558A5 (enExample)
JP2001514858A5 (enExample)
JP2010533171A5 (enExample)
JPH09511404A (ja) 呼吸器多核体ウイルスプロテインｇのペプチド断片、免疫原的薬剤、それを含む医薬組成物、および製造法
JP5407044B2 (ja) インターフェロンα変異体およびそのポリエチレングリコール誘導体
JP2006506097A5 (enExample)
CN104788556A (zh) 人胰岛素类似物及其酰化衍生物
US20250223592A1 (en) Compositions and methods for circular rna affinity purification
US20260092098A1 (en) Human a interferon receptor binding-related site mutant and use thereof
RU2005118998A (ru) Полипептиды и конъюгаты альфа-интерферона
CN112552413A (zh) 新型冠状病毒重组蛋白亚单位疫苗
CN102558362A (zh) 一种用于治疗糖尿病的融合蛋白及其制备方法
JP2003503355A5 (enExample)
CN1223605C (zh) 抑制sars冠状病毒的多肽药物及其衍生物和其应用
CN103923209B (zh) 一种Lambda干扰素突变体及聚乙二醇衍生物
CN108864292B (zh) 一种干扰素重组融合蛋白及其应用
RU2010125695A (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
JP2005512518A5 (enExample)
JP2011521648A5 (enExample)
CN105085658A (zh) 一种白细胞介素29突变体及聚乙二醇衍生物